Literature DB >> 8023846

Stored Guthrie cards as DNA "banks".

J E McEwen1, P R Reilly.   

Abstract

Recently there has been much discussion about the possibility of using dried blood spots on Guthrie cards as a source of DNA for research or testing purposes. The collections of Guthrie cards stored by state newborn-screening laboratories can thus be viewed as inchoate "DNA banks." This has generated concern among some persons who are interested in preserving the privacy of medical records. This study examines the policies of state newborn-screening laboratories in the United States, regarding their retention of Guthrie cards and the degree to which they permit the sharing of those cards with various third parties. We found that although most laboratories retain their cards, if at all, for only a short time, a growing number plan to keep them for an extended period--and, in several cases, indefinitely. We also found that although most laboratories would decline to release individually identifiable blood spots from the cards to third parties without a written release or other explicit authorization, a large number would at least consider sharing anonymous cards for research purposes.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Health Care and Public Health

Mesh:

Year:  1994        PMID: 8023846      PMCID: PMC1918213     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  3 in total

1.  DNA banking.

Authors:  P R Reilly
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

Review 2.  Utility of PCR for DNA analysis from dried blood spots on filter paper blotters.

Authors:  E R McCabe
Journal:  PCR Methods Appl       Date:  1991-11

Review 3.  A review of state legislation on DNA forensic data banking.

Authors:  J E McEwen; P R Reilly
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

  3 in total
  9 in total

Review 1.  The use of the dried blood spot sample in epidemiological studies.

Authors:  S P Parker; W D Cubitt
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Maximizing deoxyribonucleic acid yield from dried blood spots.

Authors:  Julie A Lane; Janelle A Noble
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

3.  Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA.

Authors:  V G Cheung; S F Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Amplification of Guthrie card DNA: effect of guanidine thiocyanate on binding of natural whole blood PCR inhibitors.

Authors:  G S Makowski; E L Davis; S M Hopfer
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 5.  Molecular genetic testing for adult-onset disorders: the evolving laboratory, physician, patient interface.

Authors:  R T Acton
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

6.  Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois.

Authors:  Alexa Hart; Michael Petros; Joel Charrow; Claudia Nash; Catherine Wicklund
Journal:  J Genet Couns       Date:  2014-11-20       Impact factor: 2.537

7.  Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots.

Authors:  T Nguyen-Dumont; M Mahmoodi; F Hammet; T Tran; H Tsimiklis; G G Giles; J L Hopper; M C Southey; D J Park
Journal:  Anal Biochem       Date:  2014-10-30       Impact factor: 3.365

8.  Newborn screening archives as a specimen source for epidemiologic studies: feasibility and potential for bias.

Authors:  Susan Searles Nielsen; Beth A Mueller; Anneclaire J De Roos; Harvey Checkoway
Journal:  Ann Epidemiol       Date:  2008-01       Impact factor: 3.797

9.  ACMG statement. Statement on storage and use of genetic materials. American College of Medical Genetics Storage of Genetics Materials Committee.

Authors: 
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.043

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.